Skip to content

Assessment of drug adherence and knowledge about the disease of patients with type 2 diabetes during inpatient admission to a diabetes clinic within the Rhine-Main region

Assessment of drug adherence and knowledge about the disease of patients with type 2 diabetes during inpatient admission to a diabetes clinic within the Rhine-Main region

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015850
Enrollment
60
Registered
2019-04-24
Start date
2019-03-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11

Interventions

Group 1: Patients with pre-existing type 2 diabetes and derailed blood glucose levels when hospitalized are asked once during their inpatient stay about their drug adherence and their knowledge of the

Sponsors

Chefarzt Abteilung Endokrinologie und Diabetologie Krankenhaus Sachsenhausen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age: >= 18 years, prescription of at least three medicaments, including at least one oral antidiabetic or Insulin, HbA1c level at admission >= 6.5% or admission caused by hypoglycaemia, ability to consent, ability to understand spoken and written German

Exclusion criteria

Exclusion criteria: New onset type 2 diabetes, Type 1 Diabetes, pregnancy, homecare patients, transfer of the patient to another ward, In case of diagnosis of severe comorbidities, which would significantly reduce life expectancy or require extensive systemic treatment

Design outcomes

Primary

MeasureTime frame
Drug adherence and patient knowledge about the diabetes disease Evaluation based on a structured questionnaire. The questionnaire on drug adherence is based on the adherence barriers questionnaire. The questionnaire on patient knowledge is based on the Michigan Diabetes knowledge test. The patient will be interviewed during the inpatient stay.

Secondary

MeasureTime frame
Blood sugar levels: HbA1c value and fasting blood sugar at inpatient admission

Countries

Germany

Contacts

Public ContactMichaela Pohl

Schwanen Apotheke Offenbach

michaela.pohl@schwanen-apotheke.eu069/9819467 60

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026